2026 ICD-10-CM Diagnosis Code T38.0X6AUnderdosing of glucocorticoids and synthetic analogues, initial encounter

ICD-10-CM CodesS00–T88T36-T50T38

ICD-10-CM T38.0X6A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T38.0X6A is a billable ICD-10-CM diagnosis code for underdosing of glucocorticoids and synthetic analogues, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Underdosing of drugs and medicaments, initial encounter.

Code Identity

ICD-10-CM Code
T38.0X6A
Billable Status
Yes — Valid for Submission
Code Describes
Underdosing of glucocorticoids and synthetic analogues, initial encounter
Short Description
Underdosing of glucocorticoids and synthetic analogues, init
Parent Code
Underdosing of glucocorticoids and synthetic analogues

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT38Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified
This CodeT38.0X6AUnderdosing of glucocorticoids and synthetic analogues, initial encounter

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T38.0X6A.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Coding GuidelinesGuidance

Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer's instruction. Codes for underdosing should never be assigned as principal or first-listed codes. If a patient has a relapse or exacerbation of the medical condition for which the drug is prescribed because of the reduction in dose, then the medical condition itself should be coded.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ029
Underdosing of drugs and medicaments, initial encounter
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Dexamethasone

    an anti-inflammatory 9-fluoro-glucocorticoid.
  • Dexamethasone Isonicotinate

    an anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. it may cause water and salt retention.
  • Fluprednisolone

    a synthetic glucocorticoid with anti-inflammatory properties.
  • Glucocorticoids

    a group of corticosteroids that affect carbohydrate metabolism (gluconeogenesis, liver glycogen deposition, elevation of blood sugar), inhibit adrenocorticotropic hormone secretion, and possess pronounced anti-inflammatory activity. they also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
  • Receptors, Glucocorticoid

    cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. the glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of dna. glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. cortisol is the most important example.
  • Paramethasone

    a glucocorticoid with the general properties of corticosteroids. it has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than hydrocortisone with supplementary fludrocortisone. (from martindale, the extra pharmacopoeia, 30th ed, p737)
  • Prednisolone

    a glucocorticoid with the general properties of the corticosteroids. it is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
  • Prednisone

    a synthetic anti-inflammatory glucocorticoid derived from cortisone. it is biologically inert and converted to prednisolone in the liver.
  • Triamcinolone

    a glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (from martindale, the extra pharmacopoeia, 30th ed, p739)
  • Triamcinolone Acetonide

    an esterified form of triamcinolone. it is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
AristocortT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Aristocort::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Aristocort::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Aristocort::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CelestoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Celestone::topicalT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
ClocortoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CloprednolT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-DomeT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-Dome::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-Dome::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-Dome::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortefT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortef::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortef::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortef::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CorticosteroidT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid::mineralT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid::ophthalmicT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortivazolT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortogenT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortogen::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortogen::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortone::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortone::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortrilT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortril::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortril::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortril::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DecadronT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Decadron::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Decadron::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Decadron::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DeflazacortT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DeltasoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DeltraT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DexamethasoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Dexamethasone::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Dexamethasone::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Dexamethasone::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DOCAT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
FlorinefT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Florinef::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Florinef::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Florinef::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
FluohydrocortisoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluohydrocortisone::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluohydrocortisone::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluohydrocortisone::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluorinated corticosteroidsT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
FluprednisoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluticasone propionateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
GlucocorticoidsT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
GlucocorticosteroidT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
HydeltraT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)::aceponateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
HydrocortoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortone::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortone::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortone::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
KenacortT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
MeprednisoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
ParamethasoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Paramethasone::acetateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PercortenT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PrednisoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone::steaglateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PrednisoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PrednylideneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
SteroidT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::anabolicT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::androgenicT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::antineoplastic, hormoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::antineoplastic, hormone::estrogenT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
TriamcinoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone::ENT agentT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone::hexacetonideT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone::ophthalmic preparationT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone::topical NECT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T38.0X6A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
No Map There is no ICD-9 equivalent for this code.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T38.0X6AOverview

Is T38.0X6A (Underdosing of glucocorticoids and synthetic analogues) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report underdosing of glucocorticoids and synthetic analogues, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T38.0X6A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for underdosing of glucocorticoids and synthetic analogues, such as an emergency visit or first evaluation.

Can T38.0X6A be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because underdosing of glucocorticoids and synthetic analogues, initial encounter describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.